Found: 68
Select item for more details and to access through your institution.
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 8, p. 1, doi. 10.1093/ofid/ofae409
- By:
- Publication type:
- Article
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1636, doi. 10.1002/ajh.27365
- By:
- Publication type:
- Article
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1640, doi. 10.1002/ajh.27366
- By:
- Publication type:
- Article
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 615, doi. 10.1002/ajh.27246
- By:
- Publication type:
- Article
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 588, doi. 10.1002/ajh.26824
- By:
- Publication type:
- Article
The feasibility of additional CD19‐targeted cellular therapy in relapsed/refractory B‐ALL with re‐emergence of CD19 antigen after prior CD19‐negative relapse.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E38, doi. 10.1002/ajh.26787
- By:
- Publication type:
- Article
Adoptive transfer of functional SARS‐COV‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E404, doi. 10.1002/ajh.26691
- By:
- Publication type:
- Article
High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E171, doi. 10.1002/ajh.26490
- By:
- Publication type:
- Article
Freeze‐dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 256, doi. 10.1002/ajh.26403
- By:
- Publication type:
- Article
Refractory primary autoimmune myelofibrosis treated with ruxolitinib.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E283, doi. 10.1002/ajh.26208
- By:
- Publication type:
- Article
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E196, doi. 10.1002/ajh.26157
- By:
- Publication type:
- Article
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E140, doi. 10.1002/ajh.26117
- By:
- Publication type:
- Article
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E59, doi. 10.1002/ajh.26057
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 208, doi. 10.1002/ajh.26039
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1193, doi. 10.1002/ajh.25929
- By:
- Publication type:
- Article
Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. E253, doi. 10.1002/ajh.25567
- By:
- Publication type:
- Article
Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 358, doi. 10.1002/ajh.25369
- By:
- Publication type:
- Article
Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 858, doi. 10.1002/ajh.24783
- By:
- Publication type:
- Article
Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. E18, doi. 10.1002/ajh.24604
- By:
- Publication type:
- Article
Bleeding and mortality outcomes in ITP clinical trials: A review of thrombopoietin mimetics data.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 10, p. 984, doi. 10.1002/ajh.23275
- By:
- Publication type:
- Article
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 8, p. 538, doi. 10.1002/ajh.21463
- By:
- Publication type:
- Article
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: Analysis of clinicopathologic features and activating c-kit mutations.
- Published in:
- American Journal of Hematology, 2003, v. 73, n. 1, p. 12, doi. 10.1002/ajh.10322
- By:
- Publication type:
- Article
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1114131
- By:
- Publication type:
- Article
Optimizing CAR‐T cell therapy in adults with B‐cell acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 236, doi. 10.1111/ejh.14109
- By:
- Publication type:
- Article
Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 213, doi. 10.1111/ejh.13894
- By:
- Publication type:
- Article
Cytokine gene polymorphisms are associated with response to blinatumomab in B‐cell acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 851, doi. 10.1111/ejh.13622
- By:
- Publication type:
- Article
Iron Overload in Patients Undergoing Hematopoietic Stem Cell Transplantation.
- Published in:
- Advances in Hematology, 2010, v. 2010, p. 1, doi. 10.1155/2010/345756
- By:
- Publication type:
- Article
Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome.
- Published in:
- Acta Haematologica, 2017, v. 138, n. 3, p. 129, doi. 10.1159/000479103
- By:
- Publication type:
- Article
Nodular Regenerative Hyperplasia Causing Portal Hypertension in a Patient with Chronic Graft versus Host Disease: Response to Sirolimus.
- Published in:
- Acta Haematologica, 2014, v. 132, n. 1, p. 49, doi. 10.1159/000356736
- By:
- Publication type:
- Article
The Combination of Fludarabine, Cytarabine and Etoposide Is an Active and Well-Tolerated Regimen in Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2014, v. 131, n. 4, p. 202, doi. 10.1159/000354820
- By:
- Publication type:
- Article
Iron Toxicity in Hematopoietic Stem Cell Transplantation: Strike while the Iron Is Labile.
- Published in:
- Acta Haematologica, 2014, v. 131, n. 4, p. 220, doi. 10.1159/000355827
- By:
- Publication type:
- Article
Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6568, doi. 10.3390/ijms23126568
- By:
- Publication type:
- Article
Mast cell disease associated with acute myeloid leukemia: Detection of a new c-kit mutation Asp816His.
- Published in:
- American Journal of Hematology, 2000, v. 65, n. 4, p. 307, doi. 10.1002/1096-8652(200012)65:4<307::AID-AJH10>3.0.CO;2-F
- By:
- Publication type:
- Article
Ticlopidine-induced aplastic anemia: Development of chromosomal abnormalities and response to immunosuppressive therapy.
- Published in:
- American Journal of Hematology, 2000, v. 63, n. 3, p. 141, doi. 10.1002/(SICI)1096-8652(200003)63:3<141::AID-AJH6>3.0.CO;2-T
- By:
- Publication type:
- Article
Deferasirox: appraisal of safety and efficacy in long-term therapy.
- Published in:
- Journal of Blood Medicine, 2013, v. 4, p. 101, doi. 10.2147/JBM.S35478
- By:
- Publication type:
- Article
Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Combination BCL-2 Inhibitor Therapy with Venetoclax and Navitoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S184, doi. 10.1016/j.clml.2019.07.022
- By:
- Publication type:
- Article
Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S201, doi. 10.1016/j.clml.2018.07.050
- By:
- Publication type:
- Article
Acute Lymphoblastic Leukemia (ALL) as a Second Primary Malignancy (SPM) After Multiple Myeloma (MM): Secondary Clonally Related Neoplasm or Therapy-Related Leukemia?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e29, doi. 10.1016/j.clml.2017.03.050
- By:
- Publication type:
- Article
Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.
- Published in:
- Biochemical Journal, 2015, v. 468, n. 3, p. 409, doi. 10.1042/BJ20141138
- By:
- Publication type:
- Article
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 5, p. 796, doi. 10.1007/s12282-023-01473-2
- By:
- Publication type:
- Article
Asparaginase: How to Better Manage Toxicities in Adults.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 1, p. 51, doi. 10.1007/s11912-022-01345-6
- By:
- Publication type:
- Article
Gene polymorphisms associated with diminished activity of 5,10-methylenetetrahydrofolate reductase do not explain the clinical manifestations of cobalamin deficiency.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 5, p. 907, doi. 10.1046/j.1365-2141.2003.04151_1.x
- By:
- Publication type:
- Article
Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 4, p. 1166, doi. 10.1046/j.1365-2141.2002.03729.x
- By:
- Publication type:
- Article
Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. e843, doi. 10.1093/oncolo/oyad185
- By:
- Publication type:
- Article
CPX-351 in FLT3-mutated acute myeloid leukemia.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1271722
- By:
- Publication type:
- Article
Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1237031
- By:
- Publication type:
- Article
Improving erythropoiesis: a compelling case for iron chelation in myelofibrosis.
- Published in:
- 2016
- By:
- Publication type:
- Editorial